Denali Therapeutics
PublicDenali Therapeutics is now publicly traded
The data on this page reflects Denali Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Dec 7, 2017
Last Round
Follow-on Offering
Dec 10, 2025
Total Funding Raised
$1.61B
Company Overview
Denali Therapeutics is a biotechnology company that discovers and develops innovative biotherapeutics designed to cross the blood-brain barrier for the treatment of neurodegenerative and lysosomal storage diseases.
Sector
Biotech
AI Layer
Non-AI
Keywords
biopharmaceuticalblood-brain barrierneurodegenerative diseasedrug delivery platformtransport vehicle technologyTV platformBBB deliveryCNS therapeuticsbiotech pipelineenzyme replacement therapykinase inhibitorclinical-stage biotechlysosomal storage diseasedrug licensingbiotech pharma partner
Denali Therapeutics Comparables
Compare Denali Therapeutics with similar companies based on industry and business-model similarity.
Denali Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Dec 10, 2025 | ||||
| Strategic | Dec 4, 2025 | ||||
| PIPE | Feb 27, 2024 | ||||
| IPO | Dec 7, 2017 | ||||
| Series B | Aug 25, 2016 | ||||
Series A | May 14, 2015 |
Denali Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Morgan Stanley & Co., LLC | Follow-on Offering |
| F-Prime Capital | Series B, Series A |
| Biomatics Capital Partners | Series A |
| Morgan Stanley | IPO |
| ARCH Venture Partners | Series B, Series A |
| Royalty Pharma | Strategic |
| Goldman Sachs & Co. LLC | IPO, Follow-on Offering |
Denali Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersSouth San Francisco, California
Employee Range565
Year Founded2015
Last FundingDec 10, 2025